RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
RepliCel Life Sciences Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2017 | 23.60 |
| September 28, 2017 | 27.00 |
| September 27, 2017 | 23.04 |
| September 26, 2017 | 25.60 |
| September 25, 2017 | 25.62 |
| September 22, 2017 | 28.01 |
| September 21, 2017 | 26.38 |
| September 20, 2017 | 27.37 |
| September 19, 2017 | 28.79 |
| September 18, 2017 | 26.97 |
| September 15, 2017 | 25.35 |
| September 14, 2017 | 23.97 |
| September 13, 2017 | 24.12 |
| September 12, 2017 | 23.12 |
| September 11, 2017 | 24.35 |
| September 08, 2017 | 24.68 |
| September 07, 2017 | 22.25 |
| September 06, 2017 | 22.18 |
| September 05, 2017 | 21.64 |
| September 01, 2017 | 23.28 |
| August 31, 2017 | 20.56 |
| August 30, 2017 | 20.44 |
| August 29, 2017 | 23.55 |
| August 28, 2017 | 25.08 |
| August 25, 2017 | 24.46 |
| Date | Value |
|---|---|
| August 24, 2017 | 26.66 |
| August 23, 2017 | 26.33 |
| August 22, 2017 | 25.95 |
| August 21, 2017 | 26.22 |
| August 18, 2017 | 26.22 |
| August 17, 2017 | 26.62 |
| August 16, 2017 | 26.02 |
| August 15, 2017 | 26.15 |
| August 14, 2017 | 25.72 |
| August 11, 2017 | 26.19 |
| August 10, 2017 | 25.68 |
| August 09, 2017 | 25.22 |
| August 08, 2017 | 23.68 |
| August 07, 2017 | 25.48 |
| August 04, 2017 | 25.75 |
| August 03, 2017 | 25.75 |
| August 02, 2017 | 26.83 |
| August 01, 2017 | 25.62 |
| July 31, 2017 | 25.15 |
| July 28, 2017 | 26.59 |
| July 27, 2017 | 26.83 |
| July 26, 2017 | 26.53 |
| July 25, 2017 | 27.09 |
| July 24, 2017 | 27.09 |
| July 21, 2017 | 27.68 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3953 |
| Aurinia Pharmaceuticals Inc | 1.972 |
| Edesa Biotech Inc | 3.257 |
| Lexaria Bioscience Corp | 6.165 |
| InMed Pharmaceuticals Inc | 0.2283 |
Price to Book Value Related Metrics
| PS Ratio | 8.989 |
| Price | 0.0428 |
| Earnings Yield | -0.44% |
| Market Cap | 2.785M |
| Normalized PE Ratio | 4.319 |